Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1KASTLE THERAPS LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

KASTLE THERAPS LLC

Country
2024 ACI Convention
Not Confirmed
arrow

KASTLE THERAPS LLC

Country
arrow
2024 ACI Convention
Not Confirmed

MIPOMERSEN SODIUM

Brand Name : KYNAMRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 200MG/ML (200MG/ML)

Packaging :

Approval Date : 2013-01-29

Application Number : 203568

Regulatory Info : DISCN

Registration Country : USA

blank